AA Multicenter, Randomized, Open-label Study to Evaluate the Lipid-Altering Efficacy and Safety of Ezetimibe (+) Simvastatin Versus Atorvastatin in Patients With Primary Hypercholesterolemia
Phase of Trial: Phase IV
Latest Information Update: 13 Apr 2017
At a glance
- Drugs Ezetimibe/simvastatin (Primary) ; Atorvastatin
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 27 Dec 2007 Status changed from in progress to completed according to ClinicalTrials.gov.
- 17 Dec 2005 New trial record.